SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-005055
Filing Date
2024-02-21
Accepted
2024-02-21 16:28:09
Documents
2
Period of Report
2024-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3405
2 poa_confer.htm EX-24 8543
  Complete submission text file 0001437749-24-005055.txt   13377
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Issuer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1000 SAN MARCOS ST. #460 AUSTIN TX 78702
Business Address
Confer Ryan M. (Reporting) CIK: 0001735541 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38244 | Film No.: 24660023